GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, APEX1, AXL, CA2, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, GLRA1, GSK3B, HSD17B2, IGF1R, KCNH2, KDR, MMP2, MMP9, PPARA, PPARD, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
8.67805 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, FABP3, FABP4, HSD17B1, HSD17B2, MET, MIF, PPARA, PPARD |
8.02101 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APEX1, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, GLRA1, GSK3B, HSD17B2, IGF1R, MMP2, MMP9, PPARA, PPARD, RORC, SLC6A4, SRC, TYR |
7.63287 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, HSD17B1, HSD17B2, PPARD |
7.63287 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, AKR1B1, APEX1, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GSK3B, IGF1R, KCNH2, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, XDH |
7.47631 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GLO1, GSK3B, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PPARD, PTPN1, SRC, TERT, TOP2A, XDH |
7.44255 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GSK3B, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, TYR, XDH |
7.44255 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, APEX1, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, GLRA1, GSK3B, HSD17B2, IGF1R, KDR, MMP2, PPARA, PPARD, RORC, SLC6A4, SRC, TYR |
7.36934 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA2A, AKR1B1, APEX1, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLRA1, GSK3B, IGF1R, KCNH2, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, XDH |
7.36934 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GLO1, GSK3B, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARD, PTPN1, SRC, TERT, TOP2A, XDH |
7.35058 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, GLO1, MIF, PIM1, PPARA, PPARD, TYR, XDH |
7.19825 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, CDC25B, CSNK2A1, CYP1B1, ESR1, ESRRA, FABP3, FLT3, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PPARD, SLC6A4, SRC, TERT, XDH |
6.84967 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA2A, AKR1B1, APEX1, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, ESR1, FABP3, FABP4, FLT3, GLRA1, GSK3B, HSD17B1, HSD17B2, KCNH2, KDR, MET, MIF, PPARA, PPARD, SLC6A2, SLC6A4, SRC, TERT, XDH |
6.84967 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, APEX1, AXL, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GLRA1, GSK3B, IGF1R, KCNH2, KDR, MMP2, MMP9, PPARD, RORC, SLC6A4, SRC, TERT |
6.83409 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GSK3B, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MIF, MMP1, MMP2, PIM1, PPARA, PPARD, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, TYR, XDH |
6.83409 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GLRA1, GSK3B, IGF1R, KCNH2, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, XDH |
6.7822 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GLO1, GSK3B, IGF1R, KDR, MIF, MMP9, PIM1, PPARD, PTPN1, SRC, TERT, TOP2A, XDH |
6.77304 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, GLO1, GSK3B, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PPARD, PTPN1, SRC, TERT |
6.69941 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, GLO1, GSK3B, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARD, PTPN1, SRC, TERT |
6.40379 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, APEX1, AURKB, AXL, CA2, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, GLRA1, GSK3B, HSD17B2, IGF1R, KCNH2, KDR, MIF, MMP12, MMP2, MMP9, PPARA, PPARD, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TOP2A, TYR |
6.19753 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, GLRA1, KDR, MMP9, SRC, TERT |
6.13058 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, MIF, PPARA, PPARD |
6.04523 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, APEX1, AURKB, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GLRA1, GSK3B, IGF1R, KCNH2, KDR, MIF, MMP2, MMP9, PPARD, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A |
5.83702 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, PPARD, RORC, SRC |
5.75565 |
[BP] GO:0033993 |
response to lipid
|
AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD17B2, PPARD, RORC, SLC6A4, SRC, TYR |
5.75565 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, APEX1, CA2, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GLRA1, GSK3B, IGF1R, MMP2, PPARA, SLC6A4, SRC |
5.69282 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, GLO1, GSK3B, IGF1R, KDR, MIF, MMP9, PIM1, PPARD, PTPN1, SRC, TERT |
5.68723 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GLRA1, GSK3B, IGF1R, KCNH2, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, XDH |
5.68216 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, APEX1, AURKB, AXL, CA2, CDC25B, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FABP4, FLT3, GLO1, GSK3B, HSD17B2, KDR, MET, MIF, MMP2, MMP9, PIM1, PPARA, PPARD, RORC, SLC6A4, SRC, TERT, TOP2A, TYR |
5.67155 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.66901 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARD, RORC, SRC |
5.53466 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, GSK3B, HSD17B1, HSD17B2, PPARD, TYR, XDH |
5.46084 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, AKR1B1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GSK3B, KDR, MET, MIF, MMP12, MMP9, PPARD, PTPN1, SRC, TERT, XDH |
5.46084 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, AKR1B1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GSK3B, KDR, MET, MIF, MMP12, MMP9, PPARD, PTPN1, SRC, TERT, XDH |
5.43793 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FABP4, GSK3B, MMP1, MMP12, MMP2, MMP9, PPARD, SRC, XDH |
5.41234 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, TYR |
5.32873 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, APEX1, AXL, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, GLRA1, GSK3B, IGF1R, KDR, MMP2, PPARD, RORC, SLC6A4, SRC |
5.25521 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
5.15853 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, MIF |
5.12709 |
[BP] GO:0032787 |
None
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, GLO1, MIF, PPARA, PPARD |
5.12309 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FABP4, MET, MIF, PPARA, PPARD |
5.09777 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AURKB, AXL, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GSK3B, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, TYR, XDH |
4.9959 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, MIF |
4.96457 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.86395 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARD, RORC, SRC |
4.84295 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, AKR1B1, AKR1B10, ALOX5, AXL, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, FABP4, GLRA1, HSD17B2, IGF1R, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, RORC, SLC6A2, SLC6A4, SRC, TYR |
4.83026 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, AXL, CYP1B1, ESR1, GLRA1, GSK3B, IGF1R, MMP2, MMP9, PPARD, RORC, SLC6A4, SRC |
4.81104 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, CDC25B, CSNK2A1, ESR1, FLT3, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PPARD, TERT |
4.81104 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, RORC |
4.73618 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, KDR, PPARA, PPARD, SRC, TYR |
4.73618 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, APEX1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, GSK3B, IGF1R, KCNH2, KDR, MET, MIF, MMP12, MMP9, PPARA, PPARD, PTPN1, SLC6A4, SRC, TERT |
4.71891 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, APEX1, CYP19A1, CYP1B1, IGF1R, KDR, MET, MIF, MMP9, PPARD, SRC, TERT |
4.71007 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, APEX1, CA2, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, PPARA, SLC6A4, SRC |
4.6363 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7 |
4.61286 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.57643 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AKR1B1, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, FLT3, GLRA1, GSK3B, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARD, PTPN1, SLC6A4, SRC, TERT, XDH |
4.48274 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, APEX1, CYP19A1, CYP1B1, IGF1R, KDR, MET, MIF, MMP9, PPARD, SRC, TERT |
4.41116 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, PIM1, SRC |
4.40072 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, AKR1B1, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, FLT3, GLRA1, GSK3B, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARD, PTPN1, SLC6A4, SRC, TERT, XDH |
4.38581 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, ESR1, ESR2, GLRA1, GSK3B, IGF1R, MET, MIF, MMP12, MMP9, PTPN1, SLC6A4, SRC, TERT, XDH |
4.31771 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, ESR1, ESR2, GLRA1, GSK3B, IGF1R, MET, MIF, MMP12, MMP9, PTPN1, SLC6A4, SRC, TERT, XDH |
4.30396 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, ESR1, GSK3B, PPARA, RORC, SLC6A4, SRC, TOP2A |
4.29369 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APEX1, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FLT3, RORC, SLC6A4, SRC, TYR |
4.22334 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, GLO1, MIF, PIM1, PPARA, PPARD, TYR |
4.22334 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AURKB, AXL, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GSK3B, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, TYR, XDH |
4.18716 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, AURKB, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PPARD, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, XDH |
4.17575 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, AURKB, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GSK3B, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PPARD, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, XDH |
4.16465 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, AXL, CSNK2A1, CYP1B1, FLT3, GSK3B, KDR, MET, MIF, MMP12, MMP9, PPARD, PTPN1, SRC, TERT, XDH |
4.079 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2, PPARD |
4.079 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, APEX1, AXL, CES1, CYP1A1, CYP1B1, GLRA1, KDR, SLC6A4, SRC |
4.07839 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, APEX1, CYP19A1, CYP1B1, IGF1R, KDR, MET, MIF, MMP9, PPARD, SRC, TERT |
4.0763 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, APEX1, CYP19A1, CYP1B1, IGF1R, KDR, MET, MIF, MMP9, PPARD, SRC, TERT |
4.06344 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, MIF |
3.98927 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.98927 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, AURKB, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
3.96434 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARD, RORC |
3.90707 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, GLO1, MIF, PIM1, PPARA, PPARD, TYR |
3.78871 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.76499 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, AXL, CSNK2A1, CYP1B1, ESRRA, FABP4, FLT3, GSK3B, KDR, MET, MIF, MMP12, MMP2, MMP9, PPARD, PTPN1, SRC, TERT, XDH |
3.74838 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PPARD |
3.72522 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, AXL, CA2, CYP19A1, GSK3B, KCNH2, MIF, MMP12, PPARD, SLC6A4, SRC, TERT |
3.72465 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, GLO1, MIF, PIM1, PPARA, PPARD, TYR |
3.71811 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
3.71389 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, AURKB, CDC25B, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GSK3B, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
3.69853 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, CYP19A1, ESR1, FABP4, GSK3B, IGF1R, MET, MIF, MMP12, MMP2, PPARA, PPARD, PTPN1, SRC, TERT, XDH |
3.66539 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, MMP2, PPARA, PPARD, SLC6A4, SRC, TERT |
3.64598 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, CYP19A1, ESR1, ESR2, GSK3B, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PPARD, PTPN1, SRC, TERT, XDH |
3.58331 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PPARD, SLC6A4, SRC, TERT |
3.55863 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, PPARD |
3.52654 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, AURKB, CSNK2A1, CYP1B1, ESR1, FABP4, GSK3B, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
3.52654 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, GLRA1, KDR |
3.48826 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, CYP1A1, CYP1B1, FABP3, GLRA1, KCNH2, KDR, SLC6A2, SLC6A4, SRC |
3.46105 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, AKR1B1, APEX1, AXL, CA12, CA2, CA7, ESR1, FABP3, FABP4, FLT3, KCNH2, MET, SRC, TERT |
3.41432 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, GLRA1, KCNH2, KDR, SRC |
3.40392 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PPARD |
3.39935 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, FABP3, FLT3, GLRA1, GSK3B, IGF1R, MMP2, PPARA, SLC6A4, SRC, TYR |
3.33248 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PPARD, SLC6A4, SRC, TERT |
3.32036 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARD, RORC |
3.29955 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, GSK3B, MET, MMP9, PPARA, SRC, TERT |
3.29955 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CYP1A1, ESR1, FLT3, MET, MIF, PIM1, PPARD, SRC, TYR |
3.18202 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, FABP3, PPARA, PPARD |
3.12583 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, IGF1R, KDR, MET, MIF, MMP9, PPARD, PTPN1, SRC, XDH |
3.11321 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, AXL, CA2, CYP1B1, ESR1, ESRRA, ESRRB, GLRA1, GSK3B, KCNH2, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARD, SLC6A4, SRC, TERT, XDH |
3.0956 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, FABP3, GLRA1, PPARA, PPARD |
3.07145 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, GLRA1, HSD17B2, KDR, MMP2, SLC6A4, SRC |
3.04246 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, FABP3, FLT3, GLRA1, GSK3B, IGF1R, MMP2, PPARA, SLC6A4, SRC, TYR |
3.04218 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, APEX1, ESR1, FLT3, GLRA1, GSK3B, IGF1R, MMP2, SLC6A4, SRC |
3.03144 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CES1, CSNK2A1, CYP19A1, CYP1A1, HSD17B1, HSD17B2, MIF, PPARD |
3.03134 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, AXL, CYP1B1, FLT3, KDR, MET, MIF, PPARD, PTPN1, SRC, XDH |
3.02563 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, AXL, CA2, CA7, CYP19A1, GSK3B, KCNH2, MIF, MMP12, MMP9, PPARA, PPARD, PTPN1, SLC6A4, SRC, TERT |
3.01185 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GLRA1, GSK3B, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TOP2A, TYR, XDH |
3.0013 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, APEX1, AURKB, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, GSK3B, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PPARD, PTPN1, RORC, SRC, TERT, XDH |
2.96215 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.94997 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.87855 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.86071 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, AXL, CDC25B, CYP19A1, CYP1A1, ESR1, ESRRB, GLRA1, HSD17B2, MMP2, MMP9, PPARD, SLC6A4, SRC, TOP2A |
2.84925 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FLT3, GSK3B, HSD17B2, KDR, MMP9, PIM1, PPARA, PPARD, RORC, SRC, TYR |
2.83972 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APEX1, CYP1A1, CYP1B1, ESR1, FLT3, RORC, SLC6A4, SRC |
2.82232 |
[BP] GO:0010906 |
None
|
ESRRB, GSK3B, PPARA, RORC, SRC |
2.81725 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CYP1A1, FABP3, FLT3, PPARA, RORC, SRC |
2.72217 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, ADRA2A, FLT3, MIF, PTPN1, SRC |
2.7081 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.70318 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.70194 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, MIF, PPARD |
2.68144 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, AURKB, CDC25B, CYP1A1, MIF, SLC6A4, SRC, TERT |
2.67 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, AXL, CDC25B, CES1, CYP1A1, ESR1, ESRRB, FABP4, FLT3, GLO1, GSK3B, KDR, MET, MIF, MMP2, MMP9, PPARD, RORC, SRC, TERT, TOP2A |
2.6234 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.60843 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, FABP4, FLT3, GSK3B, IGF1R, KDR, MET, MIF, MMP12, MMP2, MMP9, PPARA, PPARD, PTPN1, SRC, TERT, XDH |
2.60277 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, SRC |
2.60277 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, MIF, MMP12, PPARD, SLC6A4, SRC |
2.59686 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, APEX1, AURKB, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, GSK3B, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PPARD, PTPN1, RORC, SRC, TERT, XDH |
2.59576 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.56632 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, CDC25B, CSNK2A1, FLT3, GSK3B, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.56464 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
2.56464 |
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, MIF, PPARD |
2.56315 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.53943 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, GLRA1, GSK3B, IGF1R, MMP2, SLC6A4, SRC |
2.51261 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.48991 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.48991 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.48991 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, GSK3B, MIF, MMP2, MMP9, PPARA, PPARD, PTPN1, SLC6A2, SLC6A4, SRC, TERT, TOP2A |
2.44046 |
[BP] GO:0051271 |
None
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, MIF, PPARD |
2.43258 |
[BP] GO:0010675 |
None
|
ESRRB, GSK3B, PPARA, RORC, SRC |
2.40813 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, CES1, CYP19A1, CYP1A1, CYP1B1, PPARD, TYR |
2.39094 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.38936 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.38936 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.3478 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.3478 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CES1, CYP19A1, HSD17B1, HSD17B2 |
2.33737 |
[BP] GO:0040013 |
None
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, MIF, PPARD |
2.32315 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, CA2, CYP1A1, MMP2, PPARA, PPARD, SLC6A4, SRC, TERT, TYR |
2.32189 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FABP4, GSK3B, PPARD, SRC, XDH |
2.32161 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PPARD, TERT |
2.31346 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, GLRA1, GSK3B, IGF1R, MMP2, SLC6A4, SRC |
2.31107 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.30344 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.3023 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, ESR1, ESR2, GSK3B, IGF1R, MET, MIF, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
2.29011 |
[BP] GO:0010038 |
response to metal ion
|
CA2, CYP1A1, CYP1A2, FABP4, GLRA1, MMP9, TERT |
2.26615 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, APEX1, AURKB, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GSK3B, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, XDH |
2.26541 |
[BP] GO:0014910 |
regulation of smooth muscle cell migration
|
APEX1, PPARD, SRC, TERT |
2.26334 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.26334 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, APEX1, AURKB, AXL, CDC25B, CSNK2A1, FLT3, GSK3B, IGF1R, KCNH2, KDR, MET, PIM1, PPARD, PTPN1, SRC, XDH |
2.2588 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.25557 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.25557 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.25557 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1 |
2.23121 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA2A, AKR1B1, AXL, CA1, CA2, CSNK2A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FLT3, GLRA1, GSK3B, IGF1R, KCNH2, KDR, MET, MIF, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SRC |
2.20925 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, APEX1, AURKB, CDC25B, CSNK2A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, GLO1, GSK3B, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, XDH |
2.17024 |
[BP] GO:0006091 |
generation of precursor metabolites and energy
|
AKR1B1, AOX1, CYP19A1, CYP1A2, GSK3B, PPARD, XDH |
2.15677 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, FLT3, MIF, PTPN1, SRC |
2.15084 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.15084 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, KDR, MET, MMP12, PPARA, PPARD, RORC, SRC, TERT, TOP2A |
2.14527 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, FLT3, IGF1R, MIF, PTPN1, SRC |
2.13616 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, GSK3B, MET, MMP9, PPARA, SRC, TERT |
2.1142 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APEX1, AURKB, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, GSK3B, IGF1R, KDR, MIF, MMP12, MMP9, PPARA, PPARD, PTPN1, RORC, SRC, TERT, XDH |
2.10774 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, TERT |
2.09569 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, FABP4, GLRA1, MMP9 |
2.08407 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, FABP3, GSK3B, IGF1R, PPARA, SRC |
2.0784 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, CA2, CA7, KDR, MIF, SRC |
2.06822 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, ESR2, FLT3, GSK3B, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARD, PTPN1, SRC, TERT, XDH |
2.06545 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, APEX1, AURKB, AXL, CDC25B, CSNK2A1, FLT3, GSK3B, IGF1R, KCNH2, KDR, MET, PIM1, PPARD, PTPN1, SRC, XDH |
2.06502 |
[BP] GO:0051172 |
None
|
ADRA2A, APEX1, AURKB, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, IGF1R, MIF, MMP12, MMP9, PPARA, PPARD, PTPN1, RORC, SRC, TERT, XDH |
2.04658 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.04658 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, MIF, MMP12, PPARD, SLC6A4, SRC |
2.03923 |
[BP] GO:0071396 |
cellular response to lipid
|
AXL, ESR1, FLT3, PPARD, RORC, SLC6A4, SRC |
2.03923 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
AURKB, ESR1, ESR2, ESRRA, ESRRB, IGF1R, KDR, MET, MMP12, PPARA, PPARD, RORC, SRC, TERT, TOP2A |
2.02664 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, CDC25B, ESRRB, FABP3, FLT3, KDR, MIF, MMP9, PTPN1, SRC, XDH |
2.02664 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, CDC25B, ESRRB, FABP3, FLT3, KDR, MIF, MMP9, PTPN1, SRC, XDH |
2.02664 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.01497 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA2A, PPARD, SLC6A4, SRC |
2.01467 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, MIF |
2.00121 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AURKB, CA1, CA2, CA4, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, FABP3, FABP4, FLT3, GLO1, GLRA1, GSK3B, HSD17B1, HSD17B2, KCNH2, KDR, MIF, MMP2, MMP9, PIM1, PTPN1, SLC6A4, SRC, TERT, TOP2A, TYR, XDH |
2.17024 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, AOX1, APEX1, AURKB, AXL, CA1, CA2, CA4, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GLRA1, GSK3B, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, TYR, XDH |
2.00121 |
[CC] GO:0005783 |
None
|
ADORA1, APEX1, CA4, CES1, CES2, CYP19A1, FLT3, GLRA1, KDR, PTPN1, XDH |
1.9986 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
1.96193 |
[CC] GO:0043231 |
intracellular membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, APEX1, AURKB, CA4, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, GLO1, GLRA1, GSK3B, IGF1R, KDR, MMP12, MMP2, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, TYR, XDH |
1.75574 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, GLO1, GLRA1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, TYR, XDH |
16.1736 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GLRA1, GSK3B, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TOP2A, TYR, XDH |
10.2318 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FLT3, GLO1, GSK3B, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, SRC, TERT, TOP2A, TYR, XDH |
8.42731 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, ESR1, ESR2, ESRRA, ESRRB, GLO1, GLRA1, MMP1, MMP12, MMP2, MMP9, PPARA, PPARD, PTPN1, RORC |
8.13651 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
8.02101 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, GLO1, GLRA1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TOP2A, TYR, XDH |
7.48832 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, GLO1, GLRA1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TOP2A, TYR, XDH |
7.24033 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARD, RORC |
6.84967 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARD, RORC |
6.84967 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARD, RORC |
6.40379 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7 |
5.75565 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FLT3, GLRA1, GSK3B, IGF1R, KDR, MET, PIM1, PPARA, PPARD, SLC6A4, SRC, TOP2A |
5.15853 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.15853 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, APEX1, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A4, SRC |
4.97078 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, XDH |
4.96457 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD17B1, HSD17B2, TYR, XDH |
4.96457 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, APEX1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC |
4.58862 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, GLO1 |
4.58862 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD17B1, RORC |
4.19476 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.1905 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, TYR |
3.98927 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, GLRA1, IGF1R, KCNH2, KDR, MET, PPARA, PPARD, RORC |
3.98927 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.83449 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, CSNK2A1, ESR1, ESR2, FLT3, IGF1R, KCNH2, KDR, MET, MIF, MMP9, SLC6A4, TERT, TOP2A, TYR, XDH |
3.70611 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.65577 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.60866 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, GLRA1, IGF1R, KCNH2, KDR, MET, PPARA, PPARD, RORC |
3.36157 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, SRC |
3.34648 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD17B1, HSD17B2, XDH |
3.21091 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, GLRA1, IGF1R, KCNH2, KDR, MET, PPARA, PPARD, RORC |
3.19868 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
3.18426 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, SRC |
3.18426 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.15856 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HSD17B1, PPARA, PPARD, RORC |
3.06453 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, TYR |
2.9466 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, GLRA1, IGF1R, KCNH2, KDR, MET, PPARA, PPARD, RORC |
2.87855 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.87855 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.85876 |
[MF] GO:0008134 |
transcription factor binding
|
APEX1, ESR1, ESRRB, FLT3, GSK3B, PIM1, PPARA, PPARD, SRC, TERT |
2.82633 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD17B1, SRC, XDH |
2.70318 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.61537 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.60277 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.56464 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.48991 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.48991 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.45824 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KCNH2, KDR, MET, PIM1, SRC, TERT |
2.30149 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.27582 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.25557 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.25557 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, AURKB, CDC25B, CYP1A1, CYP1A2, CYP2C19, ESR1, ESR2, ESRRB, GSK3B, KCNH2, MET, MIF, PPARA, PTPN1, SLC6A4, SRC, TOP2A |
2.23194 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AOX1, AURKB, AXL, CSNK2A1, FABP3, FABP4, FLT3, GLRA1, GSK3B, HSD17B1, IGF1R, KDR, MET, PIM1, PPARD, SRC, TOP2A, XDH |
2.15825 |
[MF] GO:0052689 |
carboxylic ester hydrolase activity
|
ACHE, CA1, CA2, CES1, CES2 |
2.15084 |
[MF] GO:0005504 |
None
|
FABP3, FABP4, PPARD |
2.14214 |
[MF] GO:0051059 |
None
|
APEX1, GSK3B, PPARD |
2.10145 |
[MF] GO:0046983 |
protein dimerization activity
|
ACHE, ADORA1, ADRA2A, AOX1, AXL, FLT3, KCNH2, PPARD, SLC6A4, TERT, TOP2A, TYR, XDH |
2.08623 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.07505 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.00121 |